CoinInsight360.com logo CoinInsight360.com logo
America's Social Casino

CoinDesk 2025-06-18 13:10:00

Healthcare Firm Prenetics Uses Kraken to Kickoff Bitcoin Treasury

Prenetics Global Limited (NASDAQ: PRE) is the latest firm in the healthcare space to copy MicroStrategy’s $40 billion bitcoin treasury strategy, having acquired its first $20 million BTC investment, with help from global crypto exchange Kraken. There is a surge of bitcoin treasury companies that focus on accumulating bitcoin and following strategies similar to Strategy. Although the Prenetics acquisition is small by comparison to firms spending hundreds of millions of dollars on BTC, the firm said it has board approval to substantially increase its bitcoin holdings and aims to become one of the largest healthcare corporate bitcoin holders globally, in a press statement on Wednesday. “What excites me most is not just Bitcoin as a treasury asset, but the convergence we're witnessing between healthcare innovation and blockchain technology,” said Danny Yeung, CEO of Prenetics. “We're at the dawn of a new era where genomics, personalized medicine, and digital assets will intersect in ways that could revolutionize how we approach human health, longevity and wealth.” Earlier this week, H100 Group (H100), a Swedish health-technology company, announced a 750 million kronor ($79 million) transaction to support its long-term bitcoin BTC treasury strategy. Prenetics also announced the appointment of Andy Cheung, former COO of OKEx, to its Board of Directors. Read more: Trump Media and Semler Scientific Could Be Cheapest Bitcoin Treasury Companies by This Metric

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.